Farmak International Strengthens Its Presence in Spain with New Marketing Authorisations for Contrast Agents

Farmak International announces that the Spanish Agency of Medicines and Medical Devices (AEMPS) has granted Marketing Authorisations for two contrast agents for diagnostic imaging in Spain.

These approvals represent a significant step forward in the company’s expansion within the Spanish market and reflect its ongoing activities in the field of diagnostic solutions. Contrast agents are used in modern medical imaging, particularly in magnetic resonance imaging (MRI), and more broadly across diagnostic imaging modalities by enhancing the visualisation of anatomical structures and improving diagnostic accuracy. Their use, indications, and administration are defined in the approved Product Information (SmPC).

With these new authorisations, Farmak International continues to develop its diagnostic imaging portfolio in Spain.

Farmak International remains engaged in the development and supply of pharmaceutical products in accordance with applicable regulatory requirements.